ProfileGDS4132 / 239863_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 31% 30% 42% 43% 41% 33% 33% 35% 36% 36% 42% 33% 36% 42% 47% 41% 30% 36% 39% 38% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10178.02231
GSM201543Muscle PCOS pioglitazone 12163.947930
GSM201544Muscle PCOS pioglitazone 161111.93942
GSM201545Muscle PCOS pioglitazone 201120.03143
GSM201829Muscle PCOS pioglitazone 231113.5241
GSM201830Muscle PCOS pioglitazon 25186.167833
GSM201831Muscle PCOS pioglitazone 27180.444833
GSM201832Muscle PCOS pioglitazone 3189.190135
GSM201833Muscle PCOS pioglitazone 4185.073236
GSM201834Muscle PCOS pioglitazone 8188.42336
GSM201835Muscle PCOS after pioglitazone 10296.264642
GSM201836Muscle PCOS after pioglitazone 12270.290833
GSM201837Muscle PCOS after pioglitazone 16275.592336
GSM201838Muscle PCOS after pioglitazone 20298.819742
GSM201839Muscle PCOS after pioglitazone 232117.34447
GSM201840Muscle PCOS after pioglitazone 252102.3341
GSM201841Muscle PCOS after pioglitazone 27260.332330
GSM201842Muscle PCOS after pioglitazone 3273.607236
GSM201843Muscle PCOS after pioglitazone 4296.191639
GSM201844Muscle PCOS after pioglitazone 8291.311738